The US Supreme Court has overturned two methods patents on drug dose calibration held by biotech company Prometheus Laboratories, reports The Scientist's Sabrina Richards. The company's patents concerned the calibration of synthetic thiopurines, which are used to treat auto-immune diseases like Crohn's disease, Richards says. "Prometheus's methods rely on monitoring the levels of various metabolites in red blood cells," she adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.